Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
14
Citations
NaN
KQI